Personal profile
Education/Academic qualification
Dip., MBA
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Dive into the research topics where Andrew Finnerty is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 7 Article
-
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
Perico, N., Remuzzi, G., Griffin, M. D., Cockwell, P., Maxwell, A. P., Casiraghi, F., Rubis, N., Peracchi, T., Villa, A., Todeschini, M., Carrara, F., Magee, B. A., Ruggenenti, P. L., Rota, S., Cappelletti, L., McInerney, V., Griffin, T. P., Islam, M. N., Introna, M. & Pedrini, O. & 6 others, , 1 Oct 2023, In: Journal of the American Society of Nephrology. 34, 10, p. 1733-1751 19 p.Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
Open Access67 Citations (Scopus) -
GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor
Fitzgerald, J. C., Duffy, N., Cattaruzzi, G., Vitrani, F., Paulitti, A., Mazzarol, F., Mauro, P., Sfiligoj, A., Curcio, F., Jones, D. M., McInerney, V., Krawczyk, J., Kelly, J., Finnerty, A., McDonagh, K., McCabe, U., Duggan, M., Connolly, L., Shaw, G. & Murphy, M. & 1 others, , 9 Mar 2022, In: Frontiers in Bioengineering and Biotechnology. 10, 834267.Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
Open Access8 Citations (Scopus) -
Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with no-option critical limb ischemia; observations on feasibility of the autologous approach from a clinical trial.
Mcinerney, V., Finnerty, A., Liew, A., Walsh, S. R., O'Brien, T. & Howard, L., 1 Dec 2022, In: Cytotherapy. 24, 12, p. 1259-1267 9 p.Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
Open Access2 Citations (Scopus) -
Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with “no-option” critical limb ischemia; observations on feasibility of the autologous approach from a clinical trial
Mohamed, S. A., Duffy, A., McInerney, V., Krawczyk, J., Hayat, A., Naughton, S., Finnerty, A., Holohan, M., Liew, A., Tubassam, M., Walsh, S. R., O'Brien, T. & Howard, L., Dec 2022, In: Cytotherapy.Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
-
Autologous bone marrow mesenchymal stromal cell therapy for no-option critical limb ischemia is limited by karyotype abnormalities.
Liew, A., Walsh, S. R., Mcinerney, V., Howard, L., Finnerty, A. & O'Brien, T., 1 Apr 2020, In: Cytotherapy. 22, 6, p. 313-321 9 p.Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
Open Access29 Citations (Scopus)